pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 5·1 min read
save

Senate confirms Erica Schwartz as new CDC director

Aug 5, 2026·read at Endpoints ↗RegulatoryNeutral

The U.S. Senate voted 51 to 44 on Wednesday to confirm Erica Schwartz as the next director of the Centers for Disease Control and Prevention.

Schwartz, a former deputy surgeon general and a veteran of the U.S. Coast Guard, was widely expected to win confirmation.

Her appointment signals continuity in CDC leadership, a factor that pharmaceutical companies and investors will monitor as the agency shapes public-health policy and disease-response strategies.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Senate confirms Erica Schwartz as CDC director”

read at Endpoints ↗
87 words · retrieved Aug 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 15h agoAnother Novartis failure; Novo drops the ‘Nordisk’; and moreEndpoints
  • 1d agoAll 50 states sign up for most favored nation prices under Medicaid, Trump saysEndpoints
  • 1d agoFDA approves Lilly's oral SERD combo for second-line breast cancer therapyEndpoints
  • 1d agoPost-Hoc Live: The China Biotech Debate goes to WashingtonEndpoints
  • 1d agoCHMP backs Novo’s hemophilia A drug and seven other medicinesEndpoints